Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
39 GBX | +0.27% | +2.64% | -38.28% |
Mar. 27 | Jefferies Downgrades Life Science REIT to Hold from Buy, Cuts PT | MT |
Mar. 27 | Sorted renews M&S deal; Tribe completes drill build | AN |
Sales 2024 * | 19.3M 24.14M | Sales 2025 * | 23.87M 29.86M | Capitalization | 136M 170M |
---|---|---|---|---|---|
Net income 2024 * | 10M 12.51M | Net income 2025 * | 14M 17.51M | EV / Sales 2024 * | 13.8 x |
Net Debt 2024 * | 130M 163M | Net Debt 2025 * | 147M 183M | EV / Sales 2025 * | 11.8 x |
P/E ratio 2024 * |
12.5
x | P/E ratio 2025 * |
9.49
x | Employees | - |
Yield 2024 * |
7.07% | Yield 2025 * |
7.61% | Free-Float | 93.96% |
Latest transcript on Life Science REIT plc
1 day | +0.27% | ||
1 week | +2.64% | ||
Current month | -0.75% | ||
1 month | -4.64% | ||
3 months | -34.99% | ||
6 months | -37.29% | ||
Current year | -38.28% |
Members of the board | Title | Age | Since |
---|---|---|---|
Richard Howell
BRD | Director/Board Member | 59 | 22-05-02 |
Sally Forsyth
BRD | Director/Board Member | 62 | - |
Michael Taylor
BRD | Director/Board Member | 63 | 21-10-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 39 | +0.27% | 18 570 |
24-04-25 | 38.9 | +0.78% | 255,554 |
24-04-24 | 38.6 | -1.53% | 564,054 |
24-04-23 | 39.2 | +1.29% | 672,084 |
24-04-22 | 38.7 | +1.84% | 284,287 |
Delayed Quote London S.E., April 26, 2024 at 04:48 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-38.28% | 170M | |
+2.19% | 27.17B | |
+6.08% | 24.59B | |
+1.08% | 21.12B | |
-0.29% | 15.87B | |
-11.02% | 14.82B | |
-5.40% | 14.85B | |
-0.56% | 13.1B | |
-0.84% | 12.5B | |
-13.88% | 11.33B |
- Stock Market
- Equities
- LABS Stock